969 related articles for article (PubMed ID: 17173937)
1. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
[TBL] [Abstract][Full Text] [Related]
2. UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders.
de Lago E; Fernández-Ruiz J; Ortega-Gutiérrez S; Cabranes A; Pryce G; Baker D; López-Rodríguez M; Ramos JA
Eur Neuropsychopharmacol; 2006 Jan; 16(1):7-18. PubMed ID: 16006105
[TBL] [Abstract][Full Text] [Related]
3. A potent and selective inhibitor of endocannabinoid uptake, UCM707, potentiates antinociception induced by cholestasis.
Hasanein P; Javanmardi K
Fundam Clin Pharmacol; 2008 Oct; 22(5):517-22. PubMed ID: 18844724
[TBL] [Abstract][Full Text] [Related]
4. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
[TBL] [Abstract][Full Text] [Related]
5. Influence of supidimide on brain neurotransmitter systems of rats and mice.
Hennies HH; Günzler WA; Flohé L
Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
[TBL] [Abstract][Full Text] [Related]
6. Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels.
de Lago E; Petrosino S; Valenti M; Morera E; Ortega-Gutierrez S; Fernandez-Ruiz J; Di Marzo V
Biochem Pharmacol; 2005 Aug; 70(3):446-52. PubMed ID: 15963472
[TBL] [Abstract][Full Text] [Related]
7. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
Ricaurte GA; Martello AL; Katz JL; Martello MB
J Pharmacol Exp Ther; 1992 May; 261(2):616-22. PubMed ID: 1374470
[TBL] [Abstract][Full Text] [Related]
8. Anxiolytic property of estrogen related to the changes of the monoamine levels in various brain regions of ovariectomized rats.
Pandaranandaka J; Poonyachoti S; Kalandakanond-Thongsong S
Physiol Behav; 2006 Apr; 87(4):828-35. PubMed ID: 16545402
[TBL] [Abstract][Full Text] [Related]
9. Cocaine accumulates in dopamine-rich regions of primate brain after i.v. administration: comparison with mazindol distribution.
Madras BK; Kaufman MJ
Synapse; 1994 Nov; 18(3):261-75. PubMed ID: 7855738
[TBL] [Abstract][Full Text] [Related]
10. Effects of unilateral labyrinthectomy on the norepinephrine content in forebrain and cerebellar structures of albino rats.
D'Ascanio P; Arrighi P; Fascetti F; Pompeiano O
Arch Ital Biol; 2000 Jul; 138(3):241-70. PubMed ID: 10951897
[TBL] [Abstract][Full Text] [Related]
11. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
[TBL] [Abstract][Full Text] [Related]
12. The effects of acetaldehyde on nicotine-induced transmitter levels in young and adult brain areas.
Sershen H; Shearman E; Fallon S; Chakraborty G; Smiley J; Lajtha A
Brain Res Bull; 2009 Aug; 79(6):458-62. PubMed ID: 19389462
[TBL] [Abstract][Full Text] [Related]
13. Region-specific alterations in dopamine and serotonin metabolism in brains of rats exposed to low levels of lead.
Kala SV; Jadhav AL
Neurotoxicology; 1995; 16(2):297-308. PubMed ID: 7566689
[TBL] [Abstract][Full Text] [Related]
14. Effect of acute administration of hypericum perforatum-CO2 extract on dopamine and serotonin release in the rat central nervous system.
Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E
Pharmacopsychiatry; 2000 Jan; 33(1):14-8. PubMed ID: 10721879
[TBL] [Abstract][Full Text] [Related]
15. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.
Rastogi RB; Singhal RL
J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462
[TBL] [Abstract][Full Text] [Related]
16. UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide.
de Lago E; Fernández-Ruiz J; Ortega-Gutiérrez S; Viso A; López-Rodríguez ML; Ramos JA
Eur J Pharmacol; 2002 Aug; 449(1-2):99-103. PubMed ID: 12163112
[TBL] [Abstract][Full Text] [Related]
17. Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum.
Calapai G; Crupi A; Firenzuoli F; Inferrera G; Squadrito F; Parisi A; De Sarro G; Caputi A
Pharmacopsychiatry; 2001 Mar; 34(2):45-9. PubMed ID: 11302563
[TBL] [Abstract][Full Text] [Related]
18. Immediate and "day-after" effects of morphine on dopamine and serotonin metabolism in various structures of the rat brain.
Antkiewicz-Michaluk L; Romańska I; Vetulani J
Pol J Pharmacol; 1995; 47(4):355-8. PubMed ID: 8616517
[TBL] [Abstract][Full Text] [Related]
19. Effect of NOS inhibitor on forced swim test and neurotransmitters turnover in the mouse brain.
Karolewicz B; Paul IA; Antkiewicz-Michaluk L
Pol J Pharmacol; 2001; 53(6):587-96. PubMed ID: 11985332
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical studies on central dopamine neurons--regional characterization of dopamine turnover.
Hallman H; Jonsson G
Med Biol; 1984; 62(3):198-209. PubMed ID: 6492900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
